Status:
UNKNOWN
Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers
Lead Sponsor:
Ruijin Hospital
Conditions:
SARS-CoV-2 Infection
Covid19
Eligibility:
All Genders
18-59 years
Brief Summary
With the unprecedented morbidity of the COVID-19 pandemic, the vaccine effectiveness needs to be assessed across diverse populations. The purpose of this study is to evaluate the safety and immunogeni...
Detailed Description
1370 participants who were negative for serum-specific antibodies against SARS-CoV-2 at the time of screening were enrolled and were receive a two-dose schedule, 21 days apart, with 4 μg BBIBP-CorV in...
Eligibility Criteria
Inclusion
- Written informed consent according to ICH/GCP regulations prior to any trial specific procedures.
- Male or female aged 18-59 years.
Exclusion
- NA
Key Trial Info
Start Date :
January 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2023
Estimated Enrollment :
1370 Patients enrolled
Trial Details
Trial ID
NCT04795414
Start Date
January 14 2021
End Date
January 31 2023
Last Update
March 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital affiliated to Shanghai JiaoTong University School of Medicine
Shanghai, Shanghai Municipality, China